Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tolga Ozmen, M.D.

Concepts (117)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymph Node Excision6202413031.180 Why?
Lymphedema420225241.110 Why?
Breast Neoplasms192024210290.980 Why?
Mastectomy, Segmental320209720.870 Why?
Mastectomy, Subcutaneous32024560.800 Why?
Antibiotic Prophylaxis120246430.650 Why?
Axilla520246260.650 Why?
Sentinel Lymph Node Biopsy420247330.510 Why?
Surgical Wound Infection1202415270.490 Why?
Neoadjuvant Therapy2202428210.460 Why?
Microsurgery120197960.460 Why?
Nipples220242210.410 Why?
Mammaplasty1202012400.350 Why?
Lymph Nodes2202434860.280 Why?
Mastectomy4202418320.260 Why?
Anti-Bacterial Agents1202474080.260 Why?
Neoplasm, Residual3202410080.230 Why?
Cephalosporins120242040.220 Why?
Gallbladder Diseases120031370.210 Why?
Transducers120232400.200 Why?
Cholecystectomy, Laparoscopic120032310.190 Why?
Spectrum Analysis120224530.170 Why?
Breast2202019630.170 Why?
Quality of Life22020133080.160 Why?
Carcinoma, Intraductal, Noninfiltrating220249360.150 Why?
Esthetics120203260.150 Why?
Lead120238800.150 Why?
Postoperative Complications12019156790.140 Why?
Paresis220071770.130 Why?
Breast Implants120204100.130 Why?
Neoplasm Recurrence, Local2202492780.130 Why?
Insulin-Like Growth Factor Binding Proteins120162060.130 Why?
Lymphatic Metastasis2202429430.120 Why?
Insulin-Like Growth Factor Binding Protein 512014280.110 Why?
Female1920243912460.110 Why?
Hospitals, Special12014900.110 Why?
Chemotherapy, Adjuvant1202135300.110 Why?
Cosmetic Techniques120141480.100 Why?
Wound Healing2201927880.100 Why?
Prognosis62024296610.100 Why?
Survival Rate32024128100.100 Why?
Surgical Flaps1202016690.090 Why?
Spinal Neoplasms220077160.090 Why?
Telomere120169340.090 Why?
Adult1020242200070.090 Why?
Disease-Free Survival1202068310.080 Why?
Turkey320162480.080 Why?
Humans1820247606130.080 Why?
Retrospective Studies52024803450.080 Why?
Patient Selection1202042790.070 Why?
Vitamin D1202132910.070 Why?
Patient Satisfaction1202034480.070 Why?
Follow-Up Studies42024392620.070 Why?
Aged820241691430.070 Why?
Middle Aged1020242203590.070 Why?
Treatment Outcome32021649810.070 Why?
Antineoplastic Combined Chemotherapy Protocols22024117130.060 Why?
Phosphatidylinositol 3-Kinases1201428640.060 Why?
Antineoplastic Agents, Phytogenic120076260.050 Why?
Carcinoma, Ductal, Breast2202410960.050 Why?
Gallbladder120033050.050 Why?
Neoplasm Invasiveness2202436180.050 Why?
Clinical Trials as Topic1201780550.050 Why?
Paclitaxel1200717370.040 Why?
Neoplasm Staging32024111520.040 Why?
Cohort Studies22019413370.040 Why?
Radiotherapy, Adjuvant1202417910.040 Why?
Gene Expression Regulation, Neoplastic1201485120.040 Why?
Rats, Inbred F344220078250.030 Why?
Drug Delivery Systems1200722210.030 Why?
Survival Analysis32016101850.030 Why?
Neoplasm Transplantation2200720140.030 Why?
Young Adult12020587480.030 Why?
Restriction Mapping120148520.030 Why?
Frozen Sections120141530.030 Why?
Medical Oncology1202423130.020 Why?
Aged, 80 and over22014589800.020 Why?
Ultrasonography1202359610.020 Why?
Class I Phosphatidylinositol 3-Kinases120148950.020 Why?
Carcinoma, Lobular120134890.020 Why?
Mutation12014299570.020 Why?
Biopsy, Needle1201416300.020 Why?
Statistics, Nonparametric1201428520.020 Why?
Predictive Value of Tests22014152860.020 Why?
Hospitals, University120095680.020 Why?
Injections, Intralesional120072780.020 Why?
Male120243597180.020 Why?
Prospective Studies22024543060.020 Why?
Analysis of Variance1201362380.020 Why?
Polymerase Chain Reaction1201460650.010 Why?
Genetic Association Studies1201427160.010 Why?
Case-Control Studies22014220520.010 Why?
Abortion, Spontaneous120095300.010 Why?
Reoperation1201342890.010 Why?
Kaplan-Meier Estimate1201465440.010 Why?
Sequence Analysis, DNA1201447160.010 Why?
Estrogen Replacement Therapy1200912060.010 Why?
DNA Methylation1201643720.010 Why?
Rats22007237090.010 Why?
Cell Line, Tumor22007169320.010 Why?
Breast Feeding1200913550.010 Why?
Polymers1200716210.010 Why?
Adenocarcinoma2200763160.010 Why?
Early Detection of Cancer1201432020.010 Why?
Proportional Hazards Models12014125310.010 Why?
Registries1201384580.010 Why?
Disease Progression12014135050.010 Why?
Odds Ratio1200997160.010 Why?
Dose-Response Relationship, Drug12007108260.010 Why?
Risk Factors22013743330.010 Why?
Logistic Models12009133120.010 Why?
Risk Assessment12014241020.010 Why?
Age Factors12009184130.010 Why?
Smoking1200990730.010 Why?
Body Mass Index12009129140.010 Why?
Disease Models, Animal12007181370.000 Why?
Animals220071679600.000 Why?
Ozmen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (117)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.